alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcNAcp

Term ID

CHEBI:72464

Synonyms

3,5-dideoxy-5-(glycoloylamino)-D-glycero-beta-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)-[alpha-L-fucopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-glucopyranose
alpha-N-glycoloylneuraminyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosamine
alpha-Neu5Gc-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-beta-D-GlcNAc
Neu5Gca2-3Galb1-3(Fuca1-4)GlcNAcb
Neu5Gcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta

Definition

A branched amino tetrasaccharide comprising α-N-glycoloylneuraminyl, β-D-galactosyl and N-acetyl-β-D-glucosamine residues linked sequentially (2→3) and (1→3), to the galactosyl residue of which is also linked (1→4) an α-L-fucosyl residue.

References

pubmed:19443021
pubmed:31537530

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcNAcp

Phenotype where environments contain alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcNAcp

Phenotype modified by environments containing alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcNAcp

Phenotype affecting alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcNAcp

Human Disease Model